Basal cell carcinoma presenting as a delayed complication of thorium X used for treating a congenital hemangioma.
Scerri
L
L
Department of Dermatology, Derbyshire Royal Infirmary, Derby, England.
Navaratnam
A E
AE
D002280:Basal Cell Carcinoma / Q000209:etiology / Q000473:pathology*; D005153:Facial Neoplasms / Q000151:congenital / Q000473:pathology* / Q000532:radiotherapy*; D005260:Female; D006391:Hemangioma / Q000151:congenital* / Q000532:radiotherapy*; D006801:Humans; D008875:Middle Aged; D009381:Neoplasms, Radiation-Induced / Q000209:etiology / Q000473:pathology*; D016609:Neoplasms, Second Primary / Q000209:etiology / Q000473:pathology*; D011883:Radium / Q000009:adverse effects*; D012878:Skin Neoplasms / Q000151:congenital / Q000473:pathology* / Q000532:radiotherapy*; D013910:Thorium
C026062:thorium X; D013910:Thorium; D011883:Radium